Ask me later

Ask me later

How likely are you to recommend Redeye to a friend or colleague?

1

2

3

4

5

6

7

8

9

10

Not likely

Very likely

Not likely

1

2

3

4

5

6

7

8

9

10

Very likely

Message received

Thanks again for rating us!

Cantargia: Positive Results at ASCO 2022

2022-05-30

10:28

RR

Richard Ramanius

Redeye has a favourable view of the topline results presented by Cantargia at ASCO 2022, which we discuss in this note.

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers